ScholarIQanswers from OpenAlex
Drug Design Development and Therapy
JournalCitation impact & published research
Drug Design Development and Therapy is a journal indexed in ScholarIQ from OpenAlex.
How many works does Drug Design Development and Therapy have?
ScholarIQindexed works
Drug Design Development and Therapy has 5,796 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Drug Design Development and Therapy have?
ScholarIQcitation count
Drug Design Development and Therapy has 143,482 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Drug Design Development and Therapy?
ScholarIQh-index
Drug Design Development and Therapy has an h-index of 129 in OpenAlex.
What is the article processing charge of Drug Design Development and Therapy?
ScholarIQarticle processing charge
Drug Design Development and Therapy lists an article processing charge of 2,836 USD in OpenAlex.
What is the OpenAlex record for Drug Design Development and Therapy?
ScholarIQopenalex
The OpenAlex for Drug Design Development and Therapy is on the source record.
What are the most-cited papers on Drug Design Development and Therapy?
ScholarIQmost cited works
Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
Assumpta Caixàs, Lara Albert, Ismael Capel, Mercedes Rigla
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
Edward M. Wolin, Barbara Jarząb, Barbro Eriksson, Thomas Walter, Christos Toumpanakis, Michael A. Morse, Paola Tomassetti, Matthias M. Weber, David R. Fogelman, John Ramage, Donald Poon, Brian Gadbaw, Li Jiang, Janice L. Pasieka, Abakar Mahamat, Fredrik Swahn, John Newell‐Price, Wasat Mansoor, Kjell Öberg
The Risks of miRNA Therapeutics: In a Drug Target Perspective
Song Zhang, Zhujun Cheng, Yanan Wang, Tianyu Han
Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria
Xiaozhe Wu, Zhan Li, Xiaolu Li, Yaomei Tian, Yingzi Fan, Chaoheng Yu, Bailing Zhou, Yi Liu, Rong Xiang, Yang Li
Tocilizumab in the treatment of rheumatoid arthritis and beyond
Nadera Sweiss, Anjali Shetty, Rebekah L. Hanson, Peter Korsten, Shiva Arami, Suncica Volkov, Olga M Vila, William Swedler, Shiva Shahrara, Sameer Smadi, Ray Sawaqued, Munir Shawagfeh, Abdel Naser Shunaigat, David W. Perkins